EUVIMEDEUVIMED entdecken
Open Access

Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma

Alexander F Haddad, Rithvik Ramesh, Naomi Zakimi, Jia-Shu Chen, Daniel Quintana, Eugene Gil, Aymen S Kabir, Youssef E Sibih, Blanca Morales Lugo, Shubhang Bhalla, William C Chen, Javier E Villanueva-Meyer und 8 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Alexander F Haddad und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Embolization, Therapeutic, Preoperative Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Trenchard Family Charitable Fund, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preoperative embolization is hypothesized to reduce blood loss and operative time for meningioma resection, but the impact of preoperative embolization on long-term oncological outcomes and molecular features of meningiomas is incompletely understood. Here, we investigate how preoperative embolization influences perioperative and long-term outcomes as well as molecular features of atypical WHO grade 2 meningiomas.

Methods

Patients who underwent resection of WHO grade 2 meningiomas from 1997 to 2021 were retrospectively identified from an institutional database. Univariate and multivariate Cox proportional hazards modeling and propensity matching were used for clinical analyses. Available DNA methylation profiling, bulk RNA sequencing, and targeted gene expression profiling data were used to elucidate how preoperative embolization influences the molecular architecture of atypical WHO grade 2 meningiomas.

Results

A total of 319 patients with atypical WHO grade 2 meningiomas were identified, of which 106 (33.2%) underwent preoperative embolization without significant changes in perioperative outcomes, such as blood loss or operative time, in comparison to patients who did not undergo preoperative embolization. In propensity matched multivariate analyses, preoperative embolization was independently associated with longer recurrence-free survival (RFS, HR 0.55, 95% CI 0.31–0.96, P = .037), particularly in patients with subtotal resection (median RFS 16.2 years vs 5.9 years, P = .045; HR 0.32, 95% CI 0.14–0.70, P = .005). Bioinformatic analyses demonstrated that preoperative embolization led to enrichment of pathways linked to cellular differentiation and hypoxia, and suppression of pathways implicated in mitosis and cell cycle progression, suggesting that improved long-term oncological outcomes may occur through inhibition of the cell cycle in atypical WHO grade 2 meningiomas.

Conclusions

Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningiomas, a subgroup of meningiomas that have intermediate clinical outcomes with standard interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaMeningeal NeoplasmsEmbolization, TherapeuticPreoperative CareGene Expression Regulation, NeoplasticHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNeoplasm GradingPrognosisFollow-Up StudiesAdultSurvival RateBiomarkers, Tumor

Stichwörter der Autor:innen

WHO grade 2atypicaldifferentiationembolizationhypoxiameningiomamitosisrecurrencetranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Radiology, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA.
  • Department of Neurological Surgery, Northwestern University, Chicago, IL, USA.
  • Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.

ORCID-Profile: Ramin A Morshed, Michael W McDermott

Förderung

  • Trenchard Family Charitable Fund
  • NIH HHS
  • NCI NIH HHS
  • NIH

Zitieren

APA

Haddad, A. F., Ramesh, R., Zakimi, N., Chen, J. S., Quintana, D., Gil, E., Kabir, A. S., Sibih, Y. E., Lugo, B. M., Bhalla, S., Chen, W. C., Villanueva-Meyer, J. E., Narsinh, K. H., Magill, S. T., Morshed, R. A., Winkler, E., Theodosopoulos, P. V., McDermott, M. W., Aghi, M. K., & Raleigh, D. R. (2025). Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf203

Vancouver

Haddad AF, Ramesh R, Zakimi N, Chen JS, Quintana D, Gil E, et al. Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf203

BibTeX
@article{Haddad2025,
  author = {Haddad, Alexander F and Ramesh, Rithvik and Zakimi, Naomi and Chen, Jia-Shu and Quintana, Daniel and Gil, Eugene and Kabir, Aymen S and Sibih, Youssef E and Lugo, Blanca Morales and Bhalla, Shubhang and Chen, William C and Villanueva-Meyer, Javier E and Narsinh, Kazim H and Magill, Stephen T and Morshed, Ramin A and Winkler, Ethan and Theodosopoulos, Philip V and McDermott, Michael W and Aghi, Manish K and Raleigh, David R},
  title = {Preoperative embolization improves local control and modulates gene expression in atypical WHO grade 2 meningioma},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf203}
}
Kostenlos starten →